NYSE:CLB - Core Laboratories Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$67.5238 +1.16 (+1.75 %)
(As of 12/17/2018 11:23 AM ET)
Previous Close$66.36
Today's Range$65.74 - $67.83
52-Week Range$66.23 - $130.34
Volume278,685 shs
Average Volume560,429 shs
Market Capitalization$2.93 billion
P/E Ratio33.76
Dividend Yield3.32%
Beta1.66
Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
Current SymbolNYSE:CLB
Previous Symbol
CUSIPN/A
Phone31-20-420-3191

Debt

Debt-to-Equity Ratio1.83
Current Ratio2.31
Quick Ratio1.85

Price-To-Earnings

Trailing P/E Ratio33.76
Forward P/E Ratio29.36
P/E Growth2.09

Sales & Book Value

Annual Sales$659.81 million
Price / Sales4.53
Cash Flow$2.6111 per share
Price / Cash Flow25.86
Book Value$3.37 per share
Price / Book20.04

Profitability

EPS (Most Recent Fiscal Year)$2.00
Net Income$83.12 million
Net Margins13.21%
Return on Equity68.00%
Return on Assets17.17%

Miscellaneous

Employees4,600
Outstanding Shares44,220,000
Market Cap$2.93 billion
OptionableOptionable

Core Laboratories (NYSE:CLB) Frequently Asked Questions

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Tuesday, October 9th. Investors of record on Friday, October 19th will be paid a dividend of $0.55 per share on Tuesday, November 20th. This represents a $2.20 annualized dividend and a yield of 3.27%. The ex-dividend date is Thursday, October 18th. View Core Laboratories' Dividend History.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) posted its quarterly earnings results on Wednesday, October, 24th. The oil and gas company reported $0.64 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.63 by $0.01. The oil and gas company had revenue of $182.15 million for the quarter, compared to analyst estimates of $178.11 million. Core Laboratories had a return on equity of 68.00% and a net margin of 13.21%. The company's revenue was up 11.8% on a year-over-year basis. During the same quarter last year, the business earned $0.46 earnings per share. View Core Laboratories' Earnings History.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, January 30th 2019. View Earnings Estimates for Core Laboratories.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories issued an update on its fourth quarter earnings guidance on Wednesday, October, 24th. The company provided earnings per share (EPS) guidance of $0.48-0.54 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.59. The company issued revenue guidance of $173-176 million, compared to the consensus revenue estimate of $174.91 million.Core Laboratories also updated its Q4 2018 guidance to $0.48-0.54 EPS.

What price target have analysts set for CLB?

14 brokerages have issued 1 year price targets for Core Laboratories' stock. Their forecasts range from $79.00 to $130.00. On average, they anticipate Core Laboratories' share price to reach $104.30 in the next twelve months. This suggests a possible upside of 55.2% from the stock's current price. View Analyst Price Targets for Core Laboratories.

What is the consensus analysts' recommendation for Core Laboratories?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

Has Core Laboratories been receiving favorable news coverage?

Press coverage about CLB stock has been trending somewhat positive on Monday, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Core Laboratories earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave media headlines about the oil and gas company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are some of Core Laboratories' key competitors?

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the folowing people:
  • Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 63)
  • Mr. Monty L. Davis, Chief Operating Officer and Sr. VP (Age 64)
  • Mr. Richard L. Bergmark, Exec. VP (Age 65)
  • Mr. Lawrence V. Bruno, Pres & Supervisory Director (Age 58)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 48)

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include WCM Investment Management CA (11.01%), Clearbridge Investments LLC (10.92%), Vanguard Group Inc. (8.81%), Vanguard Group Inc (8.81%), BlackRock Inc. (7.35%) and Earnest Partners LLC (4.38%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland, Kevin Daniels, Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories.

Which institutional investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including WCM Investment Management CA, Renaissance Technologies LLC, Jackson Square Partners LLC, Russell Investments Group Ltd., Manning & Napier Group LLC, Clearbridge Investments LLC, Envestnet Asset Management Inc. and Sei Investments Co.. View Insider Buying and Selling for Core Laboratories.

Which institutional investors are buying Core Laboratories stock?

CLB stock was bought by a variety of institutional investors in the last quarter, including Royal London Asset Management Ltd., Epoch Investment Partners Inc., Fisher Asset Management LLC, Massachusetts Financial Services Co. MA, Select Equity Group L.P., Neuberger Berman Group LLC, Vanguard Group Inc and Vanguard Group Inc.. Company insiders that have bought Core Laboratories stock in the last two years include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $67.1968.

How big of a company is Core Laboratories?

Core Laboratories has a market capitalization of $2.93 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $2.00 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe.

What is Core Laboratories' official website?

The official website for Core Laboratories is http://www.corelab.com.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]


MarketBeat Community Rating for Core Laboratories (NYSE CLB)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  367 (Vote Outperform)
Underperform Votes:  501 (Vote Underperform)
Total Votes:  868
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/17/2018 by MarketBeat.com Staff

Featured Article: What is a Call Option?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel